Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Nitric Oxide ; 148: 1-12, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38636582

ABSTRACT

Epidemiological studies show a strong correlation between diabetes and the increased risk of developing different cancers, including melanoma. In the present study, we investigated the impact of a streptozotocin (STZ)-induced hyperglycemic environment on B16F10-Nex2 murine melanoma development. Hyperglycemic male C57Bl/6 mice showed increased subcutaneous tumor development, partially inhibited by metformin. Tumors showed increased infiltrating macrophages, and augmented IL-10 and nitric oxide (NO) concentrations. In vivo neutralization of IL-10, NO synthase inhibition, and depletion of macrophages reduced tumor development. STZ-treated TLR4 KO animals showed delayed tumor development; the transfer of hyperglycemic C57Bl/6 macrophages to TLR4 KO reversed this effect. Increased concentrations of IL-10 present in tumor homogenates of hyperglycemic mice induced a higher number of pre-angiogenic structures in vitro, and B16F10-Nex2 cells incubated with different glucose concentrations in vitro produced increased levels of IL-10. In summary, our findings show that a hyperglycemic environment stimulates murine melanoma B16F10-Nex2 primary tumor growth, and this effect is dependent on tumor cell stimulation, increased numbers of macrophages, and augmented IL-10 and NO concentrations. These findings show the involvement of tumor cells and other components of the tumor microenvironment in the development of subcutaneous melanoma under hyperglycemic conditions, defining novel targets for melanoma control in diabetic patients.


Subject(s)
Hyperglycemia , Interleukin-10 , Macrophages , Melanoma, Experimental , Mice, Inbred C57BL , Nitric Oxide , Animals , Interleukin-10/metabolism , Nitric Oxide/metabolism , Male , Hyperglycemia/metabolism , Melanoma, Experimental/metabolism , Melanoma, Experimental/pathology , Macrophages/metabolism , Macrophages/drug effects , Mice , Mice, Knockout , Cell Line, Tumor
2.
Hypertens Res ; 42(11): 1683-1691, 2019 11.
Article in English | MEDLINE | ID: mdl-31316170

ABSTRACT

Sympathetic overactivation contributes to the pathogenesis of both experimental and human hypertension. We have previously reported that oxidative stress in sympathetic premotor neurons leads to arterial baroreflex dysfunction and increased sympathetic drive to the kidneys in an experimental model of neurogenic hypertension. In this study, we hypothesized that melatonin, a potent antioxidant, may be protective in the brainstem regions involved in the tonic and reflex control of blood pressure (BP) in renovascular hypertensive rats. Neurogenic hypertension was induced by placing a silver clip (gap of 0.2 mm) around the left renal artery, and after 5 weeks of renal clip placement, the rats were treated orally with melatonin (30 mg/kg/day) by gavage for 15 days. At the end of melatonin treatment, we evaluated baseline mean arterial pressure (MAP), renal sympathetic nerve activity (rSNA), and the baroreflex control of heart rate (HR) and rSNA. Reactive oxygen species (ROS) were detected within the brainstem regions by dihydroethidium staining. Melatonin treatment effectively reduced baseline MAP and sympathoexcitation to the ischemic kidney in renovascular hypertensive rats. The baroreflex control of HR and rSNA were improved after melatonin treatment in the hypertensive group. Moreover, there was a preferential decrease in ROS within the rostral ventrolateral medulla (RVLM) and the nucleus of the solitary tract (NTS). Therefore, our study indicates that melatonin is effective in reducing renal sympathetic overactivity associated with decreased ROS in brainstem regions that regulate BP in an experimental model of neurogenic hypertension.


Subject(s)
Antioxidants/therapeutic use , Baroreflex/drug effects , Brain Stem/drug effects , Hypertension, Renovascular/drug therapy , Melatonin/therapeutic use , Animals , Antioxidants/pharmacology , Blood Pressure/drug effects , Drug Evaluation, Preclinical , Male , Melatonin/pharmacology , Rats, Wistar , Sympathetic Nervous System/drug effects
3.
Am J Hypertens ; 30(1): 28-36, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27629265

ABSTRACT

BACKGROUND: Renovascular hypertension (2-kidney 1-clip model (2K1C)) is characterized by renin-angiotensin system (RAS) activation. Increased Angiotensin II (AngII) leads to sympathoexcitation, oxidative stress, and alterations in sodium and water balance. AIM: The aim of this study was to evaluate whether a discrete increase in sodium chloride intake in 2K1C rats leads to changes in cardiovascular and autonomic function, oxidative stress, and renin angiotensin aldosterone system. METHODS: After 4 weeks of induction of hypertension, rats were fed a normal sodium diet (0.4% NaCl) or a high-sodium diet (2% NaCl) for 2 consecutive weeks. Experiments were carried out for 6 weeks after clipping. Mean arterial pressure (MAP), renal sympathetic nerve activity (rSNA), arterial baroreflex control of rSNA, and heart rate (HR) were assessed. Thiobarbituric acid reactive substances and glutathione were measured as indicators of systemic oxidative stress. Angiostensin-converting enzyme (ACE), ACE2, and angiotensinogen were evaluated in clipped and unclipped kidneys as also urinary angiotensinogen and plasma renin activity. Angiotensinogen, plasma renin activity (PRA) and angiotensin-converting enzyme (ACE) and ACE2 in clipped and unclipped kidneys were evaluated. RESULTS: High-sodium diet did not change systemic oxidative stress, and basal values of MAP, HR, or rSNA; however, increased renal (-0.7±0.2 vs. -1.5±0.1 spikes/s/mm Hg) and cardiac (-0.9±0.14 vs. -1.5±0.14 bpm/mm Hg) baroreceptor reflex sensitivity in 2K1C rats. Although there was no alteration in PRA, a high-salt diet significantly decreased urinary angiotensinogen, ACE, and ACE2 expressions in the clipped and unclipped kidneys. CONCLUSIONS: Increased arterial baroreceptor control associated with a suppression of the intrarenal RAS in the 2K1C rats on high-salt diet provide a salt-resistant effect on hypertension and sympathoexcitation in renovascular hypertensive rats.


Subject(s)
Hypertension, Renovascular/physiopathology , Pressoreceptors/physiopathology , Renin-Angiotensin System , Sodium Chloride, Dietary/adverse effects , Animals , Heart Rate , Hypertension, Renovascular/urine , Male , Oxidative Stress , Pressoreceptors/drug effects , Rats, Wistar , Sodium Chloride/adverse effects
4.
Cell Biol Int ; 40(7): 796-802, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27109745

ABSTRACT

Much attention has been drawn to the pro-inflammatory condition that accompanies aging. This study compared parameters from non-stimulated neutrophils, obtained from young (18-30 years old [y.o.]) and elderly (65-80 y.o.) human volunteers. Measured as an inflammatory marker, plasmatic concentration of hs-CRP was found higher in elderly individuals. Non-stimulated neutrophil production of ROS and NO was, respectively, 38 and 29% higher for the aged group. From the adhesion molecules evaluated, only CD11b expression was elevated in neutrophils from the aged group, whereas no differences were found for CD11a, CD18, or CD62. A 69% higher non-stimulated in vitro neutrophil/endothelial cell adhesion was observed for neutrophils isolated from elderly donors. Our results suggest that with aging, neutrophils may be constitutively producing more reactive species in closer proximity to endothelial cells of vessel walls, which may both contribute to vascular damage and reflect a neutrophil intracellular disrupted redox balance, altering neutrophil function in aging.


Subject(s)
Endothelial Cells/cytology , Neutrophils/cytology , Adult , Age Factors , Aged , Aging/physiology , Antigens, CD/metabolism , C-Reactive Protein/metabolism , CD11b Antigen/metabolism , Cell Adhesion/physiology , Cell Adhesion Molecules/metabolism , Endothelial Cells/metabolism , Endothelium, Vascular/cytology , Endothelium, Vascular/metabolism , Female , Humans , Male , Neutrophils/metabolism , Reactive Oxygen Species/metabolism
5.
Am J Hypertens ; 26(7): 858-65, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23485486

ABSTRACT

BACKGROUND: Previous studies showed that the microinjection of antioxidants or the overexpression of superoxide dismutase within the rostral ventrolateral medulla (RVLM) reduces hypertension and sympathoexcitation in the 2-kidney, 1-clip (2K-1C) model. In this study, we hypothesized that angiotensin II (ANG II) type 1 receptor (AT1R) is involved in the oxidative stress within the RVLM and contributes to cardiovascular dysfunction in renovascular hypertension. METHODS: Losartan (30mg/kg/day, oral gavage) was administered for 7 consecutive days by week 5 after implantation of the clip (gap width = 0.2mm). Mean arterial pressure, baroreflex, and renal sympathetic nerve activity (rSNA) were evaluated. Superoxide production was evaluated by dihydroethidium (DHE) staining within the RVLM and within a control area. Systemic oxidative stress was characterized by measurement of thiobarbituric acid reactive substances (TBARS) and total glutathione (tGSH) in the blood. RESULTS: AT1R blockade significantly (P < 0.05) reduced hypertension by approximately 20% (n = 11) and sympathoexcitation to the kidneys by approximately 41% (n = 6) in the 2K-1C rats. Losartan treatment increased the baroreflex sensitivity of rSNA to pressor (67%) and depressor (140%) stimuli in the 2K-1C rats. AT1R blockade caused a significant (66%) reduction in DHE staining within the RVLM but not within the control area, reduced plasma TBARS (from 1.6±0.1 to 1.0±0.1 nmol/ml), and increased tGSH (from 3.4±0.4 to 5.2±0.3 µmol/g Hb) in the 2K-1C group only. CONCLUSIONS: Our findings suggest that the beneficial effects of ANG II blockade in renovascular hypertension are partly due to preferential reduction of oxidative stress in the RVLM.


Subject(s)
Hypertension, Renovascular/drug therapy , Losartan/therapeutic use , Oxidative Stress/drug effects , Superoxide Dismutase/biosynthesis , Ventral Thalamic Nuclei/enzymology , Angiotensin II Type 1 Receptor Blockers , Animals , Arterial Pressure/drug effects , Baroreflex/physiology , Disease Models, Animal , Hypertension, Renovascular/metabolism , Hypertension, Renovascular/physiopathology , Male , Rats , Rats, Wistar , Superoxide Dismutase/drug effects , Thiobarbituric Acid Reactive Substances/metabolism , Treatment Outcome , Ventral Thalamic Nuclei/drug effects
6.
Oxid Med Cell Longev ; 2013: 609019, 2013.
Article in English | MEDLINE | ID: mdl-24454987

ABSTRACT

Alzheimer's disease (AD) is a late-onset, progressive degenerative disorder that affects mainly the judgment, emotional stability, and memory domains. AD is the outcome of a complex interaction among several factors which are not fully understood yet; nevertheless, it is clear that oxidative stress and inflammatory pathways are among these factors. 65 elderly subjects (42 cognitively intact and 23 with probable Alzheimer's disease) were selected for this study. We evaluated erythrocyte activities of superoxide dismutase, catalase, and glutathione peroxidase as well as plasma levels of total glutathione, α-tocopherol, ß-carotene, lycopene, and coenzyme Q10. These antioxidant parameters were confronted with plasmatic levels of protein and lipid oxidation products. Additionally, we measured basal expression of monocyte HLA-DR and CD-11b, as well as monocyte production of cytokines IL1-α, IL-6, and TNF-α. AD patients presented lower plasmatic levels of α-tocopherol when compared to control ones and also higher basal monocyte HLA-DR expression associated with higher IL-1α production when stimulated by LPS. These findings support the inflammatory theory of AD and point out that this disease is associated with a higher basal activation of circulating monocytes that may be a result of α-tocopherol stock depletion.


Subject(s)
Alzheimer Disease/pathology , Oxidative Stress , Aged , Aged, 80 and over , Alzheimer Disease/blood , Alzheimer Disease/enzymology , Antioxidants/metabolism , Cytokines/blood , Erythrocytes/enzymology , Erythrocytes/pathology , Flow Cytometry , Humans , Monocytes/pathology , Oxidation-Reduction
7.
Drug Chem Toxicol ; 35(3): 324-9, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22288377

ABSTRACT

Expression of cytochrome P4502E1 (CYP2E1) is very much influenced by nutritional factors, especially carbohydrate consumption, and various results concerning the expression of CYP2E1 were obtained with a low-carbohydrate diet. This study describes the effects of ethanol treatment on CYP2E1 levels and its relationship with oxidative stress using a balanced standard diet to avoid low or high carbohydrate consumption. Rats were fed for 1, 2, 3, or 4 weeks a commercial diet plus an ethanol-sucrose solution. The results have shown that ethanol administration was associated with CYP2E1 induction and stabilization without related oxidative stress. Our findings suggest that experimental models with a low-carbohydrate/high-fat diet produce some undesirable CYP2E1 changes that are not present when a balanced standard diet is given.


Subject(s)
Cytochrome P-450 CYP2E1/metabolism , Diet , Enzyme Induction/drug effects , Ethanol/toxicity , Liver/drug effects , Oxidative Stress/drug effects , Alanine Transaminase/blood , Analysis of Variance , Animals , Aspartate Aminotransferases/blood , Ethanol/administration & dosage , Glutathione/metabolism , Male , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Statistics, Nonparametric
SELECTION OF CITATIONS
SEARCH DETAIL
...